ZFPM2 and central nervous system cancer: The regulatory mechanism of the SP1/ZFPM2-AS1/miR-515-5p/SOD2 axis in gliomas was confirmed by a study, suggesting that ZFPM2-AS1 targeting could be a useful treatment strategy [108].